Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ortho-McNeil-Janssen ends collaboration with Arena Pharma for APD-597 program

Nov. 5, 2010

Kowa claims new erythropoietin production enhancers

Nov. 5, 2010

Primary endpoint met in phase III HPN-100 trial in urea cycle disorders

Nov. 4, 2010

ENB-0040 shows promise to treat hypophosphatasia in children

Nov. 4, 2010

New neuropeptide Y5 receptor antagonists discovered

Nov. 3, 2010

FDA responds to Biodel regarding Linjeta NDA

Nov. 3, 2010

Novartis and Xenon Pharma claim new acyl-CoA desaturase inhibitors

Nov. 3, 2010

Protalix BioTherapeutics reports on taliglucerase alfa switchover trial

Nov. 3, 2010

New modulators of G protein-coupled receptors disclosed

Nov. 3, 2010

GSK and Amicus to develop Amigal for Fabry's disease

Nov. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...